Predictive Oncology (POAI)
(Delayed Data from NSDQ)
$1.66 USD
+0.32 (23.88%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.66 0.00 (0.00%) 7:14 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.66 USD
+0.32 (23.88%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.66 0.00 (0.00%) 7:14 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of -18.18% and 0.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
NantHealth, Inc. (NH) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
NantHealth, Inc. (NH) delivered earnings and revenue surprises of -11.11% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
1Life Healthcare, Inc. (ONEM) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
1Life Healthcare, Inc. (ONEM) delivered earnings and revenue surprises of -2.04% and 5.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Predictive Oncology Inc. (POAI) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Predictive Oncology Inc. (POAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Predictive Oncology Inc. (POAI) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Predictive Oncology Inc. (POAI) delivered earnings and revenue surprises of 20.00% and -82.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Predictive Oncology Inc. (POAI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
by Zacks Equity Research
Predictive Oncology Inc. (POAI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Company News for Mar 13, 2020
by Zacks Equity Research
Companies In The News Are: POAI, APT, AQST, TACO